文献速递类风湿关节炎

胞外氨酰-tRNA合成酶通过释放细胞因子和PAD4驱动类风湿关节炎的自身免疫与炎症反应

Extracellular aaRSs drive autoimmune and inflammatory responses in rheumatoid arthritis via the release of cytokines and PAD4.
PubMed 文献 · Ann Rheum Dis · 2023-07-02

研究在体外用氨酰-tRNA合成酶(aaRSs)刺激原代巨噬细胞和成纤维样滑膜细胞,检测细胞因子与PAD4释放,并测定类风湿关节炎(RA)患者血清和滑膜液中aaRS水平;发现全部20种aaRS均作为警报素经CD14-MD2-TLR4轴诱导促炎细胞因子,RA患者多种aaRS水平升高,aaRS抑制肽可减轻两种小鼠RA模型关节炎症状。

要点

  • 全部20种aaRS均作为警报素经CD14-MD2-TLR4轴诱导促炎细胞因子。
  • RA患者血清和滑膜液中多种aaRS水平较对照升高。
  • aaRS抑制肽在小鼠RA模型中减轻关节炎症状。

核心结论

  • 研究发现aaRSs作为新型警报素在RA发病中起重要作用,提示其阻断剂是有效的抗风湿药物。

研究设计与样本

  • 体外培养原代巨噬细胞和成纤维样滑膜细胞并用aaRSs刺激,采用ELISA检测细胞因子、RNA测序分析转录组、免疫沉淀和western blot检测瓜氨酸化。
  • 采用ELISA检测RA患者血清和滑膜液aaRS水平,并与对照比较。
  • 在胶原诱导性关节炎和胶原抗体诱导性关节炎两种小鼠RA模型中使用aaRS抑制肽抑制关节炎。

主要发现

  • 全部20种aaRS均作为警报素,经CD14-MD2-TLR4轴诱导促炎细胞因子。
  • 用aaRSs刺激巨噬细胞显示持续的固有炎症反应。
  • RA患者血清和滑膜液中多种aaRS水平较对照升高。
  • aaRSs从活巨噬细胞释放PAD4,导致其自身瓜氨酸化。
  • aaRS抑制肽抑制aaRSs诱导的细胞因子产生和PAD4释放,并减轻小鼠RA模型关节炎症状。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: Recent studies demonstrate that extracellular-released aminoacyl-tRNA synthetases (aaRSs) play unique roles in immune responses and diseases. This study aimed to understand the role of extracellular aaRSs in the pathogenesis of rheumatoid arthritis (RA). METHODS: Primary macrophages and fibroblast-like synoviocytes were cultured with aaRSs. aaRS-induced cytokine production including IL-6 and TNF-α was detected by ELISA. Transcriptomic features of aaRS-stimulated macrophages were examined using RNA-sequencing. Serum and synovial fluid (SF) aaRS levels in patients with RA were assessed using ELISA. Peptidyl arginine deiminase (PAD) 4 release from macrophages stimulated with aaRSs was detected by ELISA. Citrullination of aaRSs by themselves was examined by immunoprecipitation and western blotting. Furthermore, aaRS inhibitory peptides were used for inhibition of arthritis in two mouse RA models, collagen-induced arthritis and collagen antibody-induced arthritis. RESULTS: All 20 aaRSs functioned as alarmin; they induced pro-inflammatory cytokines through the CD14-MD2-TLR4 axis. Stimulation of macrophages with aaRSs displayed persistent innate inflammatory responses. Serum and SF levels of many aaRSs increased in patients with RA compared with control subjects. Furthermore, aaRSs released PAD4 from living macrophages, leading to their citrullination. We demonstrate that aaRS inhibitory peptides suppress cytokine production and PAD4 release by aaRSs and alleviate arthritic symptoms in a mouse RA model. CONCLUSIONS: Our findings uncovered the significant role of aaRSs as a novel alarmin in RA pathogenesis, indicating that their blocking agents are potent antirheumatic drugs.

来源:Ann Rheum Dis,查看原文。版权归原作者所有。

引用

  1. Kimura A, Takagi T, Thamamongood T, et al. Extracellular aaRSs drive autoimmune and inflammatory responses in rheumatoid arthritis via the release of cytokines and PAD4. Ann Rheum Dis. 2023. PMID: 37400117. doi:10.1136/ard-2023-224055

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。